Trials / Completed
CompletedNCT01557010
Evaluate the Efficacy and Safety of DWP05195 in Subjects With Post-Herpetic Neuralgia
The Clinical Trial for Evaluation of Efficacy and Safety of DWP05195 in Postherpetic Neuralgia: Double-blind, Placebo-controlled, Randomized, Multi-center, Exploratory Clinical Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 140 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate efficacy, safety of administered DWP05195 in Postherpetic Neuralgia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWP05195 | Tablets, oral administration, 100mg |
| DRUG | DWP05195 | Tablets, oral administration, 200mg |
| DRUG | DWP05195 | Tablets, oral administration, 300mg |
| DRUG | Control | Tablets, oral administration, Placebo |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2013-11-01
- Completion
- 2013-12-01
- First posted
- 2012-03-19
- Last updated
- 2014-02-21
Source: ClinicalTrials.gov record NCT01557010. Inclusion in this directory is not an endorsement.